June 30 (Reuters) - Cynata Therapeutics Ltd (CYP) :
- APPOINTMENT OF KILIAN KELLY TO POSITION OF CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR
- APPOINTMENT OF KILIAN KELLY FOLLOWING RETIREMENT OF ROSS MACDONALD
News: CYP Cynata Therapeutics Appoints Kilian Kelly As Chief Executive Officer And Managing Director
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18498 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 9741 | 3 |
View Market Depth
| Last trade - 10.06am 15/09/2025 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable